Skip to content
Press Releases

AIM-HI Accelerator Fund Celebrates Yiviva’s Milestone Collaboration With Astrazeneca China, Furthering Technology Platforms For Multiple Cancers

AIM-HI Accelerator Fundis proud to celebrate a significant milestone in the journey of one of its esteemed portfolio companies, Yiviva. A clinical-stage platform biotechnology company, Yiviva has entered into a Memorandum of Understanding (MOU) with AstraZeneca China, a multinational biopharmaceutical leader. AIM-HI was established with a focused goal of supporting bold new ideas in detecting,…

Media

A Shared Vision – AngeLink Powered by Women Series

If AngeLink has a guardian angel, she may well be Dr. Sujuan Ba, Ph.D., who was recently featured as One of the 20 Most Inspiring Women Leaders of 2022 by The Women Leaders Magazine. “Sujuan believed in my vision for AngeLink before anyone else,” says AngeLink Founder and CEO Gerry Poirier. “She is the ‘definition’…

AIM-HI Accelerator Fund Nominated for the 2022 Prix Galien USA Incubators, Accelerators and Equity Award

The AIM-HI Accelerator Fund is honored to be nominated for the 2022 Prix Galien USA Incubators, Accelerators and Equity Award. The newest Prix Galien Award category, “Incubators, Accelerators and Equity,” acknowledges the role played by organizations in guiding the next wave of innovators, by offering a range of mentoring skills including clinical trial design expertise,…

Leading Game-changing Discoveries | Sujuan Ba, Ph.D.

We’re excited that Dr. Sujuan Ba, AIM-HI CEO & Co-Founder, is featured as one of the “20 Most Inspiring Women Leaders 2022” by THE WOMEN LEADERS Magazine. Read about her illustrious career leading three successful non-profits in the field of cancer research, all the while paving the way for Women in Life Sciences. Her vision has…

Support Our Mission

Together, we can make the next generation of cancer treatments a reality.

Back To Top